| TTM
|
7/31/2025
|
7/31/2024
|
7/31/2023
|
7/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
|
0 | -- | 0 | -0.1560 | -1.9500 |
|
Gross Profit
|
0 | -- | 0 | -0.1560 | -1.9500 |
| Selling, General and Administrative Expenses
|
-156.0330 | -118.6200 | -174.1900 | -170.7140 | -182.6230 |
|
Exploration Expenses
|
0 | -- | 0 | -8.1540 | 0 |
| Other Income/Expense, Operating
|
-168.8160 | -110.9540 | -133.7250 | -186.6950 | -221.2270 |
|
Operating Income/Expenses
|
-324.8490 | -229.5740 | -307.9150 | -365.5630 | -403.8500 |
|
Total Operating Profit/Loss
|
-324.8490 | -229.5740 | -307.9150 | -365.7190 | -405.8000 |
| Net Investment Income
|
42.2010 | -10.3450 | -45.4160 | -45.3870 | 0 |
| Irregular Income/Expenses
|
-159.8890 | -158.2760 | -181.7680 | -218.4160 | -886.8840 |
|
Other Income/Expense, Non-Operating
|
0 | -- | 0 | 1.3120 | 142.8340 |
|
Non-Operating Income/Expenses, Total
|
-112.6880 | -168.6210 | -227.1840 | -262.4910 | -744.0500 |
|
Pretax Income
|
-437.5370 | -398.1950 | -535.0990 | -628.2100 | -1,149.8500 |
|
Net Income from Continuing Operations
|
-437.5370 | -398.1950 | -535.0990 | -628.2100 | -1,149.8500 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-437.5370 | -398.1950 | -535.0990 | -628.2100 | -1,149.8500 |
|
Net Income after Non-Controlling/Minority Interests
|
-437.5370 | -398.1950 | -535.0990 | -628.2100 | -1,149.8500 |
|
Net Income Available to Common Stockholders
|
-437.5370 | -398.1950 | -535.0990 | -628.2100 | -1,149.8500 |
|
Diluted Net Income Available to Common Stockholders
|
-437.5370 | -398.1950 | -535.0990 | -628.2100 | -1,149.8500 |
| Basic EPS
|
-0.01 | -0.01 | -0.02 | -0.02 | -0.04 |
| Diluted EPS
|
-0.01 | -0.01 | -0.02 | -0.02 | -0.04 |
|
Basic Weighted Average Shares Outstanding
|
31,286.3020 | 28,511.5760 | 28,511.5760 | 28,275.2290 | 26,518.4040 |
|
Diluted Weighted Average Shares Outstanding
|
31,286.3020 | 28,511.5760 | 28,511.5760 | 28,275.2290 | 26,518.4040 |
|
EBIT
|
-437.5370 | -398.1950 | -535.0990 | -628.2100 | -1,149.8500 |
|
EBITDA
|
-437.5370 | -398.1950 | -535.0990 | -628.0540 | -1,147.9000 |
|
Normalized EBITDA
|
-265.6130 | -189.9290 | -276.9380 | -364.2510 | -261.0160 |
|
Normalized Income
|
-265.6130 | -189.9290 | -276.9380 | -364.4070 | -262.9660 |
|
Total Unusual Items
|
171.9240 | 208.2660 | 258.1610 | 263.8030 | 886.8840 |
|
Total Unusual Items Excluding Goodwill
|
171.9240 | 208.2660 | 258.1610 | 263.8030 | 886.8840 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
7/31/2022 - 8/8/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade